| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_HIPK2_0013800 | Intron-Intron | chr7:139464032-139464198 | chr7:139764233-139764399 | 167 nt | 0.4192 |
| hsa_HIPK2_0013900 | Intron-Intron | chr7:139465470-139466254 | chr7:139765671-139766455 | 785 nt | 0.4497 |
| hsa_HIPK2_0014000 | Intron-Intron | chr7:139465885-139466692 | chr7:139766086-139766893 | 808 nt | 0.4530 |
| hsa_HIPK2_0014100 | Intron-Intron | chr7:139466419-139470488 | chr7:139766620-139770689 | 284 nt | 0.4507 |
| hsa_HIPK2_0014200 | Intron-Intron | chr7:139469848-139470444 | chr7:139770049-139770645 | 250 nt | 0.4480 |
| hsa_HIPK2_0014300 | Intron-Intron | chr7:139469848-139470488 | chr7:139770049-139770689 | 139 nt | 0.4388 |
| hsa_chr7_0191900 | Intergenic-Intergenic | chr7:139475095-139475297 | chr7:139775296-139775498 | 203 nt | 0.4483 |
A study in mice demonstrated that knockdown of the circHIPK2 via siRNA lentivirus microinjection into the hippocampus significantly inhibited methamphetamine- or LPS-induced astrocyte activation, autophagy, and ER stress in vivo [Huang et al. DOI:10.1080/15548627.2017.1356975].